Sabdariffa cannabina
Sabdariffa cannabina · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Sabdariffa cannabina is a botanical species currently under investigation for its potential medicinal properties. Research focuses on evaluating the plant's efficacy against the deadly parasite Plasmodium falciparum. Scientists specifically examine the bioactive potential found within the root and seed components of the plant. Various formulations, including general extracts and specific methanol extracts, are utilized to test these biological activities. Understanding these phytochemical properties may lead to new therapeutic strategies for managing malaria.
- Synonyms
- Ketmia Glandulosa · Abelmoschus Congener · 13 more
- Common names
- Not available
- Family
- Malvaceae
- Distribution
- Not available
- Plant Parts
- Root · Seed
Classification
Common Names
Sabdariffa cannabina is a versatile plant known by a diverse array of regional and descriptive names. It is frequently referred to as Ambari Hemp or Bastard Jute, reflecting its unique botanical characteristics. In various contexts, the species is also identified as Brown Indianhemp or Rosella. Depending on the local culture, it may be called Cadillo in the Dominican Republic. Finally, the plant is recognized as Deccan hemp, illustrating the wide geographic reach of its many monikers.
Sources: Catalogue of Life (COL)
Synonyms
Sabdariffa cannabina is a botanically complex species that is recognized by several different scientific names. Within various taxonomic records, it is frequently identified by the synonyms Abelmoschus congener and Abelmoschus verrucosus. The plant is also documented under the historical nomenclature of Furcaria cannabina and Furcaria cavanillesii. Additionally, many researchers and databases list the species as Hibiscus cannabinus. Understanding these various synonyms is essential for maintaining clarity when studying the plant's diverse biological classifications.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Sabdariffa cannabina is a distinctive organism that belongs to the vast kingdom Plantae. Within this expansive realm, it is specifically classified under the class Equisetopsida. The plant's evolutionary lineage continues through the order Malvales, which helps define its structural characteristics. It further resides within the diverse family Malvaceae, sharing traits with many other well-known flowering plants. Ultimately, its botanical identity is solidified by its placement within the genus Sabdariffa.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malvales |
| Family | Malvaceae |
| Genus | Sabdariffa |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Sabdariffa cannabina is widely distributed across various regions of the African continent. Within East Tropical Africa, this plant is commonly found throughout Kenya, Tanzania, and Uganda. Its presence also extends to the Northeast Tropical region, specifically within the borders of Chad. Additionally, the species can be found in the Macaronesia region, notably in Cape Verde. This broad geographic range highlights the plant's adaptability to diverse African environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Compounds
Conditions
Sabdariffa cannabina, also referred to as Hibiscus cannabinus, demonstrates significant therapeutic potential across several biological targets. The plant extracts show effective growth inhibition against A549 lung adenocarcinoma cells. Furthermore, it exhibits potent bactericidal activity against NDM-1 producing Escherichia coli IR-6 by disrupting bacterial cell wall integrity. The extracts also possess highly potent antimalarial properties specifically against Plasmodium falciparum. These diverse activities suggest that the plant contains bioactive compounds capable of treating cancer, antibiotic-resistant bacteria, and malaria.
Preparations
Sabdariffa cannabina is prepared as extracts to facilitate the study of its medicinal properties. Specifically, the plant is prepared as a methanol extract for specialized pharmacological evaluation. These preparation methods allow researchers to isolate bioactive compounds for testing. Such extraction processes are essential for determining the plant's potential therapeutic effects. Consequently, the use of methanol extracts serves as a key technique in analyzing its biological activity.
Parts used
Sabdariffa cannabina, also known as Hibiscus cannabinus, offers significant therapeutic potential through its various biological components. Research indicates that the plant's seed contains a polyphenolic-rich extract that demonstrates strong antioxidant and enzyme inhibitory activities. These seed extracts have shown promise in managing diabetes and neuroprotective targets through both in vitro and in silico studies. Additionally, the root of the species has been investigated for its potent hepatoprotective qualities against drug-induced liver damage. Together, these findings highlight how different parts of the plant can serve as valuable sources for developing new medicinal compounds.